28
Participants
Start Date
January 31, 1996
Primary Completion Date
July 31, 2000
Study Completion Date
February 29, 2004
O6-benzylguanine
Patients receive BG IV over 1 hour during week 1, and then BG IV over 1 hour during week 3. Courses repeat every 6 weeks in the absence of disease progression or unacceptable toxicity.
carmustine
After one hour of receiving BG patients receive BCNU IV over 1 hour during week 3. Courses repeat every 6 weeks in the absence of disease progression or unacceptable toxicity.
chemosensitization/potentiation therapy
Veterans Affairs Medical Center - Cleveland, Cleveland
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland
National Cancer Institute (NCI)
NIH
Case Comprehensive Cancer Center
OTHER